A detailed history of Cwm, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 100 shares of LXRX stock, worth $83. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 67 49.25%
Holding current value
$83
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$1.51 - $2.39 $49 - $78
33 Added 49.25%
100 $0
Q2 2024

Jul 09, 2024

BUY
$1.54 - $2.28 $100 - $148
65 Added 3250.0%
67 $0
Q1 2024

Apr 05, 2024

BUY
$1.3 - $3.58 $2 - $7
2 New
2 $0
Q2 2023

Aug 03, 2023

BUY
$2.15 - $3.49 $494 - $802
230 New
230 $1,000
Q2 2020

Jul 22, 2020

BUY
$1.75 - $2.3 $1,750 - $2,300
1,000 New
1,000 $2,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.